Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1999
03/18/1999WO1999012966A1 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012963A2 Cysteine rich receptors: trail
03/18/1999WO1999012962A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
03/18/1999WO1999012961A1 Estrogen receptor
03/18/1999WO1999012960A2 P13 ANTIGENS FROM $i(BORRELIA)
03/18/1999WO1999012959A1 Carbohydrate crosslinked glycoprotein crystals
03/18/1999WO1999012952A1 Mammalian circadian rhythm-like gene
03/18/1999WO1999012948A2 Protein-coated polyribonucleic acids, method for the production thereof, and use of the same
03/18/1999WO1999012572A1 Compounds and method for the prevention and treatment of diabetic retinopathy
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012564A1 Bovine footrot treatment and prevention
03/18/1999WO1999012563A2 Mucosal cytotoxic t lymphocyte responses
03/18/1999WO1999012561A2 FRACTURE HEALING USING PTHrP ANALOGS
03/18/1999WO1999012558A1 Inhibitors of collagen assembly
03/18/1999WO1999012557A1 Novel prokaryotic polynucleotides, polypeptides and their uses
03/18/1999WO1999012556A1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
03/18/1999WO1999000516A3 Neuronal stem cell gene
03/18/1999WO1999000490A3 Attenuated human immunodeficiency virus vaccine
03/18/1999WO1999000410A3 Human extracellular matrix proteins
03/18/1999WO1998058955A3 Nuclear matrix targeting peptides and uses therefor
03/18/1999WO1998058954A3 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
03/18/1999WO1998058953A3 Surface exposed proteins from chlamydia pneumoniae
03/18/1999WO1998057992A3 Anti-flip protein antibodies
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999WO1998057983A3 Mammalian neuro-growth factor like protein
03/18/1999WO1998057982A3 Aib1, a steroid receptor co-activator
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999WO1998056901A3 Live attenuated vaccines
03/18/1999WO1998055510A3 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
03/18/1999WO1998046722A9 Direct expression of peptides into culture media
03/18/1999WO1998044103A3 Protein for inhibiting apoptosis
03/18/1999DE19740735A1 Antibodies specific for Borrelia burgdorferi 24 kD antigen OspC
03/18/1999DE19738710A1 A novel T-cell transmembrane protein (TIRC7)
03/18/1999CA2323936A1 Estrogen receptor
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303486A1 Stabilization of helicobacter urease
03/18/1999CA2303484A1 Plus end-directed microtubule motor required for chromosome congression
03/18/1999CA2303480A1 Mpl ligand analogs
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303462A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303410A1 Mucosal cytotoxic t lymphocyte responses
03/18/1999CA2303404A1 Reagents and methods useful for detecting diseases of the prostate
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2302807A1 Dsrna/dsrna-binding protein methods and compositions
03/18/1999CA2302705A1 Secreted proteins and polynucleotides encoding them
03/18/1999CA2302647A1 Expression of gonadotropins in dictyostelium
03/18/1999CA2302148A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2301969A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
03/18/1999CA2301830A1 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
03/18/1999CA2301684A1 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
03/18/1999CA2301173A1 Cysteine rich receptors-train
03/18/1999CA2300958A1 Bovine footrot treatment and prevention
03/18/1999CA2300365A1 P13 antigens from borrelia
03/18/1999CA2300221A1 Retro-inverso neurotrophic and analgesic peptides
03/18/1999CA2244241A1 Novel phoh
03/17/1999EP0902089A2 Disease resistant plant including thionin gene
03/17/1999EP0902088A2 Peptides with antiproliferative properties
03/17/1999EP0902087A2 Histidine kinase
03/17/1999EP0902086A1 Tuberculosis vaccine
03/17/1999EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/17/1999EP0902036A1 Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
03/17/1999EP0902034A2 Very large scale immobilized peptide synthesis
03/17/1999EP0901530A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/17/1999EP0901529A2 Teichoic acid enzymes and assays
03/17/1999EP0901526A1 Cortistatin: neuropeptides, compositions and methods
03/17/1999EP0901525A2 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
03/17/1999EP0901524A1 Intracellular antifreeze polypeptides and nucleic acids
03/17/1999EP0901504A1 Zona pellucida proteins for contraception
03/17/1999EP0901503A1 Synthetic glucagon binding proteins
03/17/1999EP0901502A1 Lytic peptides
03/17/1999EP0901379A2 Type-2 chemokine binding proteins and methods of use therefor
03/17/1999EP0740792B1 Peptomers with enhanced immunogenicity
03/17/1999EP0733065B1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
03/17/1999EP0728148B1 Improved immunogenic compositions against human gastrin 17
03/17/1999EP0692026B1 A human t-cell receptor of the g-protein coupled receptor family
03/17/1999EP0648222A4 Methods of single nucleotide primer extension to detect specific alleles and kits therefor.
03/17/1999EP0616613B1 Fragments of prion proteins
03/17/1999EP0614465B1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG
03/17/1999EP0585310B1 Crosstalk inhibitors and their uses
03/17/1999EP0563296B1 Optimization of binding proteins
03/17/1999EP0558631B1 Recombinant avirulent salmonella antifertility vaccines
03/17/1999EP0485611B1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
03/17/1999CN1211321A Methods for measurment and treatment predicated on presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
03/17/1999CN1211280A Thrombin muteins as antidotes for thrombin inhibitors
03/17/1999CN1211279A Composition and methods for the treatment and diagnosis of breast cancer
03/17/1999CN1211255A Ob receptor and method of diagnosing and treating weight
03/17/1999CN1211192A Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
03/17/1999CN1210889A Method for preparing monomer insulin
03/17/1999CN1210866A Preparation of recombinant factor VIII in protein free medium
03/17/1999CA2244330A1 Novel histidine kinase
03/17/1999CA2215898A1 Medicament
03/16/1999US5883293 Conformationally constrained backbone cyclized peptide analogs
03/16/1999US5883256 Process for removing aromatic heterocyclic compounds product-containing solutions
03/16/1999US5883230 Multidomain hematopoiesis stimulators
03/16/1999US5883229 Bcl-y is involved in mediating cell death or survival
1 ... 2300 2301 2302 2303 2304 2305 2306 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 ... 2916